News

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

- Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell Therapies…

1 year ago

The Naderi Center for Plastic Surgery and Dermatology Reveals Updated Website for Virginia and Maryland Patients

The Naderi Center's website upgrade offers comprehensive procedure insights and booking. RESTON, VIRGINIA / ACCESSWIRE / December 18, 2024 /…

1 year ago

CBD Life Sciences Inc. (CBDL) Announces 3.5 Billion Share Reduction From the Authorization

Demonstrating shareholder confidence, CBDL commits to repurchasing 10% of revenue quarterly. SCOTTSDALE, AZ / ACCESSWIRE / December 18, 2024 /…

1 year ago

Interactive Strength Inc. (Nasdaq:TRNR) Secures 162 Unit CLMBR Commitment and Signs Exclusive Distribution Agreement With Planet Fitness SAS for France

Three-Year Agreement Expected to Generate more than $0.5million in Revenue, and Covers France and French RegionsFrance is the Second-Largest Fitness…

1 year ago

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

From giving AI the sense of smell and breakthrough in rare disease treatments, Ainos is shaping 2025 with bold technologies…

1 year ago

Braille Institute Library to Host Livestream Event with Pulitzer Prize Finalist Andrew Leland on January 16, 2025

Leland to discuss his best-selling book, “The Country of the Blind: A Memoir at the End of Sight” LOS ANGELES,…

1 year ago

BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions

Collaboration will leverage BioAge's differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to…

1 year ago

Rafarma pharmaceutical updates

Sheridan, Wyoming, USA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA)  Dear Rafarma shareholders, We apologize for the…

1 year ago

T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor

Multiple instrument sale demonstrates growing market penetration of T2 Biosystems’ sepsis testsLEXINGTON, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- T2…

1 year ago

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

Bagsværd, Denmark, 18 December 2024 — Today, Novo Nordisk completed its acquisition of three manufacturing sites from Novo Holdings A/S. The…

1 year ago